A new treatment for multiple sclerosis (MS) using stem cells from a patient's own fat tissue has provided promising results, according to a series of case studies.
Published in the Journal of Translational Medicine, the trials - conducted by the University of California San Diego - revealed that stromal vascular fraction (SVF) cells could provide promising new treatments for MS and a range of other autoimmune diseases.
Dr Boris Minev, a neurology expert at the university, revealed that all three patients showed "dramatic improvement" in their condition after being administered with the treatment.
"While obviously no conclusions in terms of therapeutic efficacy can be drawn from these reports, this first clinical use of fat stem cells for treatment of MS supports further investigations into this very simple and easily-implementable treatment methodology," he added.
Stem cells have made a number of headlines recently - earlier this week, it was reported that they were used in a pioneering new reconstructive treatment for a woman who had undergone corrective breast surgery.